1-11 of 11
Rosemarie Mick
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma

Thomas M. Anderson, Bryan H. Chang, Alexander C. Huang, Xiaowei Xu, Daniel Yoon, Catherine G. Shang, Rosemarie Mick, Erin Schubert, Suzanne McGettigan, Kristin Kreider, Wei Xu, E. John Wherry, Lynn M. Schuchter, Ravi K. Amaravadi, Tara C. Mitchell, Michael D. Farwell
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (9): 1758–1767.
https://doi.org/10.1158/1078-0432.CCR-23-2390
Published: 01 May 2024
View article titled, FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma
Open the PDF for FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma in another window
Includes: Supplementary data
Journal Articles

BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced BRAFV600-mutant Melanoma

Janice M. Mehnert, Tara C. Mitchell, Alexander C. Huang, Tomas S. Aleman, Benjamin J. Kim, Lynn M. Schuchter, Gerald P. Linette, Giorgos C. Karakousis, Sheryl Mitnick, Lydia Giles, Mary Carberry, Noelle Frey, Andrew Kossenkov, Roman Groisberg, Leonel F. Hernandez-Aya, George Ansstas, Ann W. Silk, Sunandana Chandra, Jeffrey A. Sosman, Phyllis A. Gimotty, Rosemarie Mick, Ravi K. Amaravadi
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (6): 1098–1106.
https://doi.org/10.1158/1078-0432.CCR-21-3382
Published: 15 March 2022
View article titled, BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced <em>BRAFV600</em>-mutant Melanoma
Open the PDF for BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced <em>BRAFV600</em>-mutant Melanoma in another window
Includes: Supplementary data
Journal Articles

Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer

Katelyn T. Byrne, Courtney B. Betts, Rosemarie Mick, Shamilene Sivagnanam, David L. Bajor, Daniel A. Laheru, E. Gabriela Chiorean, Mark H. O'Hara, Shannon M. Liudahl, Craig Newcomb, Cécile Alanio, Ana P. Ferreira, Byung S. Park, Takuya Ohtani, Austin P. Huffman, Sara A. Väyrynen, Andressa Dias Costa, Judith C. Kaiser, Andreanne M. Lacroix, Colleen Redlinger, Martin Stern, Jonathan A. Nowak, E. John Wherry, Martin A. Cheever, Brian M. Wolpin, Emma E. Furth, Elizabeth M. Jaffee, Lisa M. Coussens, Robert H. Vonderheide
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (16): 4574–4586.
https://doi.org/10.1158/1078-0432.CCR-21-1047
Published: 15 August 2021
View article titled, Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer
Open the PDF for Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer in another window
Includes: Supplementary data
Journal Articles

Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2pos DCIS Independent of Route: Results of Randomized Selection Design Trial

Lea Lowenfeld, Rosemarie Mick, Jashodeep Datta, Shuwen Xu, Elizabeth Fitzpatrick, Carla S. Fisher, Kevin R. Fox, Angela DeMichele, Paul J. Zhang, Susan P. Weinstein, Robert E. Roses, Brian J. Czerniecki
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2017) 23 (12): 2961–2971.
https://doi.org/10.1158/1078-0432.CCR-16-1924
Published: 14 June 2017
View article titled, Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2<sup>pos</sup> DCIS Independent of Route: Results of Randomized Selection Design Trial
Open the PDF for Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2<sup>pos</sup> DCIS Independent of Route: Results of Randomized Selection Design Trial in another window
Includes: Supplementary data
Journal Articles

A Dendritic Cell Vaccine Pulsed with Autologous Hypochlorous Acid-Oxidized Ovarian Cancer Lysate Primes Effective Broad Antitumor Immunity: From Bench to Bedside

Cheryl Lai-Lai Chiang, Lana E. Kandalaft, Janos Tanyi, Andrea R. Hagemann, Gregory T. Motz, Nikolaos Svoronos, Kathleen Montone, Gina M. Mantia-Smaldone, Lori Smith, Harvey L. Nisenbaum, Bruce L. Levine, Michael Kalos, Brian J. Czerniecki, Drew A. Torigian, Daniel J. Powell, Jr, Rosemarie Mick, George Coukos
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (17): 4801–4815.
https://doi.org/10.1158/1078-0432.CCR-13-1185
Published: 02 September 2013
View article titled, A Dendritic Cell Vaccine Pulsed with Autologous Hypochlorous Acid-Oxidized Ovarian Cancer Lysate Primes Effective Broad Antitumor Immunity: From Bench to Bedside
Open the PDF for A Dendritic Cell Vaccine Pulsed with Autologous Hypochlorous Acid-Oxidized Ovarian Cancer Lysate Primes Effective Broad Antitumor Immunity: From Bench to Bedside in another window
Includes: Supplementary data
Journal Articles

Collapse of the CD27+ B-Cell Compartment Associated with Systemic Plasmacytosis in Patients with Advanced Melanoma and Other Cancers

Erica L. Carpenter, Rosemarie Mick, Andrew J. Rech, Gregory L. Beatty, Theresa A. Colligon, Myrna R. Rosenfeld, David E. Kaplan, Kyong-Mi Chang, Susan M. Domchek, Peter A. Kanetsky, Leslie A. Fecher, Keith T. Flaherty, Lynn M. Schuchter, Robert H. Vonderheide
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (13): 4277–4287.
https://doi.org/10.1158/1078-0432.CCR-09-0537
Published: 01 July 2009
View article titled, Collapse of the CD27+ B-Cell Compartment Associated with Systemic Plasmacytosis in Patients with Advanced Melanoma and Other Cancers
Open the PDF for Collapse of the CD27+ B-Cell Compartment Associated with Systemic Plasmacytosis in Patients with Advanced Melanoma and Other Cancers in another window
Journal Articles

Motexafin Lutetium-Photodynamic Therapy of Prostate Cancer: Short- and Long-Term Effects on Prostate-Specific Antigen

Hiral Patel, Rosemarie Mick, Jarod Finlay, Timothy C. Zhu, Elizabeth Rickter, Keith A. Cengel, S. Bruce Malkowicz, Stephen M. Hahn, Theresa M. Busch
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (15): 4869–4876.
https://doi.org/10.1158/1078-0432.CCR-08-0317
Published: 01 August 2008
View article titled, Motexafin Lutetium-Photodynamic Therapy of Prostate Cancer: Short- and Long-Term Effects on Prostate-Specific Antigen
Open the PDF for Motexafin Lutetium-Photodynamic Therapy of Prostate Cancer: Short- and Long-Term Effects on Prostate-Specific Antigen in another window
Journal Articles

A Phase II Trial of Intraperitoneal Photodynamic Therapy for Patients with Peritoneal Carcinomatosis and Sarcomatosis

Stephen M. Hahn, Douglas L. Fraker, Rosemarie Mick, James Metz, Theresa M. Busch, Debbie Smith, Timothy Zhu, Carmen Rodriguez, Andreea Dimofte, Francis Spitz, Mary Putt, Stephen C. Rubin, Chandrakala Menon, Hsing-Wen Wang, Daniel Shin, Arjun Yodh, Eli Glatstein
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (8): 2517–2525.
https://doi.org/10.1158/1078-0432.CCR-05-1625
Published: 25 April 2006
View article titled, A Phase II Trial of Intraperitoneal Photodynamic Therapy for Patients with Peritoneal Carcinomatosis and Sarcomatosis
Open the PDF for A Phase II Trial of Intraperitoneal Photodynamic Therapy for Patients with Peritoneal Carcinomatosis and Sarcomatosis in another window
Journal Articles

A Phase I Study of Topical Tempol for the Prevention of Alopecia Induced by Whole Brain Radiotherapy

James M. Metz, Debbie Smith, Rosemarie Mick, Robert Lustig, James Mitchell, Murali Cherakuri, Eli Glatstein, Stephen M. Hahn
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (19): 6411–6417.
https://doi.org/10.1158/1078-0432.CCR-04-0658
Published: 08 October 2004
View article titled, A Phase I Study of Topical Tempol for the Prevention of Alopecia Induced by Whole Brain Radiotherapy
Open the PDF for A Phase I Study of Topical Tempol for the Prevention of Alopecia Induced by Whole Brain Radiotherapy in another window
Journal Articles

Combined 5-Fluorouracil/Systemic Interferon-β Gene Therapy Results in Long-Term Survival in Mice with Established Colorectal Liver Metastases

Eugene A. Choi, Hanqin Lei, David J. Maron, Rosemarie Mick, James Barsoum, Qian-chun Yu, Douglas L. Fraker, James M. Wilson, Francis R. Spitz
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (4): 1535–1544.
https://doi.org/10.1158/1078-0432.CCR-0040-03
Published: 20 February 2004
View article titled, Combined 5-Fluorouracil/Systemic Interferon-β Gene Therapy Results in Long-Term Survival in Mice with Established Colorectal Liver Metastases
Open the PDF for Combined 5-Fluorouracil/Systemic Interferon-β Gene Therapy Results in Long-Term Survival in Mice with Established Colorectal Liver Metastases in another window
Journal Articles

Local Recurrence in Head and Neck Cancer: Relationship to Radiation Resistance and Signal Transduction

Anjali K. Gupta, W. Gillies McKenna, Charles N. Weber, Michael D. Feldman, Jeffrey D. Goldsmith, Rosemarie Mick, Mitchell Machtay, David I. Rosenthal, Vincent J. Bakanauskas, George J. Cerniglia, Eric J. Bernhard, Randal S. Weber, Ruth J. Muschel
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (3): 885–892.
Published: 01 March 2002
View article titled, Local Recurrence in Head and Neck Cancer: <subtitle>Relationship to Radiation Resistance and Signal Transduction</subtitle>
Open the PDF for Local Recurrence in Head and Neck Cancer: <subtitle>Relationship to Radiation Resistance and Signal Transduction</subtitle> in another window